Post by Gilead Sciences on X
Gilead Sciences@GileadSciences
X#GileadNews: Today, in collaboration with @Merck, we announced positive topline results from a Phase 3 study evaluating an investigational long-acting oral HIV treatment. Read the full press release here: t.co
15 likes1 repliesPosted Jun 8, 2026